Download White Paper: The Role of PCR Testing in Transplant Infections Management

Transplantation often represents the only curative option for patients with serious health conditions such as end-stage organ failure or certain high-risk hematologic malignancies. Due to the prolonged immunosuppressive status of transplant patients, infections represent a significant cause of morbidity and mortality in this patient cohort. Therefore, clinical laboratories and the testing options they provide are essential for improving patient outcomes by facilitating the screening, diagnosis, and treatment response monitoring of infected transplant patients.

This white paper covers the types of transplant-associated infections, the role of testing in transplant infection management, the importance of PCR technology, and improving the standard of care.

Please complete the form below to access the white paper.  



I would like to speak with a Thermo Fisher Scientific representative to learn more about transplant infection testing solutions, or to receive a quote.